Skip to main content
Equibles

David Hastings

CFO

Trevi Therapeutics, Inc. (TRVI)

Board Member

Scynexis Inc (SCYX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Hastings

David Hastings is recorded as CFO at Trevi Therapeutics, Inc. (TRVI) and Board Member at Scynexis Inc (SCYX). Trevi Therapeutics, Inc. reported in an 8-K filed December 5, 2025 that David Hastings was appointed Chief Financial Officer and principal financial officer, effective January 6, 2026. David Hastings has spoken on 2 earnings calls across 1 company, most recently for Trevi Therapeutics, Inc. on August 6, 2026.

“On December 4, 2025, Trevi Therapeutics, Inc. (the "Company") announced the hiring of David Hastings to serve as the Company's Chief Financial Officer and principal financial officer, effective January 6, 2026.”
Trevi Therapeutics, Inc. Form 8-K, filed December 5, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Trevi Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Scynexis Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.